BioCentury
ARTICLE | Company News

GlaxoSmithKline board of directors update

December 10, 2007 8:00 AM UTC

GlaxoSmithKline plc (LSE:GSK, GSK), London, U.K. Business: Pharmaceuticals Appointed: Andrew Witty, CEO designate, as executive director; and Chris Viehbacher, president of GSK's U.S. pharmaceuticals ...